To the Editor.

Congratulations to Drs Benitz, Gould, and Druzin for their comprehensive review of the clinical risk factors for the acquisition of early-onset group B streptococcal sepsis (EOGBS),¹ the risk reduction attributable to various antibiotic intervention,² and the cost-effectiveness of various EOGBS prevention strategies.³ Their analysis is the most elegant to date, enhancing our understanding of efficient, cost-effective prevention of this often devastating disease.

Nevertheless, as we move increasingly toward a capitated payment schedule for obstetric and newborn services, I found it curious that the authors chose . . . [Full Text of this Article]